BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wieczorek E, Reszka E. mRNA, microRNA and lncRNA as novel bladder tumor markers. Clin Chim Acta 2018;477:141-53. [PMID: 29224950 DOI: 10.1016/j.cca.2017.12.009] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 9.2] [Reference Citation Analysis]
Number Citing Articles
1 Liu H, Jiang G, Liu L, Xue L, Li Y, Wu Y, Yang R. Multicomponent Cu@Cu2O@C hybrid-induced photocurrent polarity switching biosensing strategy for the detection of TK1 mRNA. Sensors and Actuators B: Chemical 2022;372:132631. [DOI: 10.1016/j.snb.2022.132631] [Reference Citation Analysis]
2 Chen Y, Qian H, He X, Zhang J, Xue S, Wu Y, Chen J, Wu X, Zhang S, Zheng M. Screening of the Key Genes for the Progression of Liver Cirrhosis to Hepatocellular Carcinoma Based on Bioinformatics. Journal of Oncology 2022;2022:1-17. [DOI: 10.1155/2022/2515513] [Reference Citation Analysis]
3 Wu Y, Wang Z, Yu S, Liu D, Sun L. LncmiRHG-MIR100HG: A new budding star in cancer. Front Oncol 2022;12:997532. [DOI: 10.3389/fonc.2022.997532] [Reference Citation Analysis]
4 Yang T, Li Y, Wang G, Guo L, Sun F, Li S, Deng X, Liu J, Shen Y. lncRNA MIR4435-2HG Accelerates the Development of Bladder Cancer through Enhancing IQGAP3 and CDCA5 Expression. BioMed Research International 2022;2022:1-17. [DOI: 10.1155/2022/3858249] [Reference Citation Analysis]
5 Li D, Wang X, Yi T, Zhang L, Feng L, Zhang M, He Y, Gang S. LncRNA MINCR attenuates osteoarthritis progression via sponging miR-146a-5p to promote BMPR2 expression. Cell Cycle 2022;:1-16. [PMID: 35848848 DOI: 10.1080/15384101.2022.2099191] [Reference Citation Analysis]
6 Chen K, Zhu S, Yu W, Xia Y, Xing J, Geng J, Cheng F. Comprehensive Analysis of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Tumor Microenvironment of Bladder Cancer. Front Oncol 2022;12:774307. [DOI: 10.3389/fonc.2022.774307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Zhang C, Zhang W, Cui H, Zhang B, Miao P, Yang Q, Bai M, Jiao H, Chang D. Role of Hub Genes in the Occurrence and Development of Testicular Cancer Based on Bioinformatics. IJGM 2022;Volume 15:645-60. [DOI: 10.2147/ijgm.s342611] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Chen Y, Long W, Yang L, Zhao Y, Wu X, Li M, Du F, Chen Y, Yang Z, Wen Q, Yi T, Xiao Z, Shen J. Functional Peptides Encoded by Long Non-Coding RNAs in Gastrointestinal Cancer. Front Oncol 2021;11:777374. [PMID: 34888249 DOI: 10.3389/fonc.2021.777374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Yang L, Sun HF, Guo LQ, Cao HB. MiR-10a-5p: A Promising Biomarker for Early Diagnosis and Prognosis Evaluation of Bladder Cancer. Cancer Manag Res 2021;13:7841-50. [PMID: 34703308 DOI: 10.2147/CMAR.S326732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Gareev I, Gileva Y, Dzidzaria A, Beylerli O, Pavlov V, Agaverdiev M, Mazorov B, Biganyakov I, Vardikyan A, Jin M, Ahmad A. Long non-coding RNAs in oncourology. Noncoding RNA Res 2021;6:139-45. [PMID: 34504983 DOI: 10.1016/j.ncrna.2021.08.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
11 Shan L, Liu W, Zhan Y. LncRNA HAND2-AS1 exerts anti-oncogenic effects on bladder cancer via restoration of RARB as a sponge of microRNA-146. Cancer Cell Int 2021;21:361. [PMID: 34238300 DOI: 10.1186/s12935-021-02063-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
12 Wang X, Ou H, Zhou L, Liu H, Liu X, Zhang H. Long non-coding RNA LUCAT1 promotes the progression of clear cell renal cell carcinoma via the microRNA-375/YAP1 axis. Exp Ther Med 2021;22:754. [PMID: 34035851 DOI: 10.3892/etm.2021.10186] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Shen P, He X, Lan L, Hong Y, Lin M. Identification of cell division cycle 20 as a candidate biomarker and potential therapeutic target in bladder cancer using bioinformatics analysis. Biosci Rep 2020;40:BSR20194429. [PMID: 32677673 DOI: 10.1042/BSR20194429] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Lan Y, Liu B, Guo H. The role of M6A modification in the regulation of tumor-related lncRNAs. Mol Ther Nucleic Acids 2021;24:768-79. [PMID: 33996258 DOI: 10.1016/j.omtn.2021.04.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 15.0] [Reference Citation Analysis]
15 Cao W, Zhou G. LncRNA SNHG12 contributes proliferation, invasion and epithelial-mesenchymal transition of pancreatic cancer cells by absorbing miRNA-320b. Biosci Rep 2020;40:BSR20200805. [PMID: 32432698 DOI: 10.1042/BSR20200805] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 14.0] [Reference Citation Analysis]
16 Zhou LL, Zhang M, Zhang YZ, Sun MF. Long non-coding RNA PSMA3-AS1 enhances cell proliferation, migration and invasion by regulating miR-302a-3p/RAB22A in glioma. Biosci Rep 2020;40:BSR20191571. [PMID: 32894281 DOI: 10.1042/BSR20191571] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
17 Zhao Y, Hong L. lncRNA-PRLB Confers Paclitaxel Resistance of Ovarian Cancer Cells by Regulating RSF1/NF-κB Signaling Pathway. Cancer Biotherapy and Radiopharmaceuticals 2021;36:202-10. [DOI: 10.1089/cbr.2019.3363] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
18 Wu Y, Li Q, Zhang R, Dai X, Chen W, Xing D. Circulating microRNAs: Biomarkers of disease. Clin Chim Acta 2021;516:46-54. [PMID: 33485903 DOI: 10.1016/j.cca.2021.01.008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 30.0] [Reference Citation Analysis]
19 Zhang XW, Li QH, Xu ZD, Dou JJ. STAT1-induced regulation of lncRNA ZFPM2-AS1 predicts poor prognosis and contributes to hepatocellular carcinoma progression via the miR-653/GOLM1 axis. Cell Death Dis 2021;12:31. [PMID: 33414427 DOI: 10.1038/s41419-020-03300-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 20.0] [Reference Citation Analysis]
20 Yu J, Fang C, Zhang Z, Zhang G, Shi L, Qian J, Xiong J. H19 Rises in Gastric Cancer and Exerts a Tumor-Promoting Function via miR-138/E2F2 Axis. Cancer Manag Res 2020;12:13033-42. [PMID: 33376397 DOI: 10.2147/CMAR.S267357] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
21 Meng L, Xing Z, Guo Z, Liu Z. LINC01106 post-transcriptionally regulates ELK3 and HOXD8 to promote bladder cancer progression. Cell Death Dis 2020;11:1063. [PMID: 33311496 DOI: 10.1038/s41419-020-03236-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
22 Song RX, Zhu GJ, Dong CM, Wang ZP. WITHDRAWN: Novel diagnostic and prognostic value of circulating miR-18a in the plasma of patients with bladder cancer. Clin Biochem 2020:S0009-9120(20)30921-8. [PMID: 33316224 DOI: 10.1016/j.clinbiochem.2020.12.006] [Reference Citation Analysis]
23 Chen SH, Lin F, Zhu JM, Ke ZB, Lin TT, Lin YZ, Xue XY, Wei Y, Zheng QS, Chen YH, Xu N. An immune-related lncRNA prognostic model in papillary renal cell carcinoma: A lncRNA expression analysis. Genomics 2021;113:531-40. [PMID: 32979493 DOI: 10.1016/j.ygeno.2020.09.046] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
24 Gao Z, Li S, Zhou X, Li H, He S. Knockdown of lncRNA ZNRD1-AS1 inhibits progression of bladder cancer by regulating miR-194 and ZEB1. Cancer Med 2020;9:7695-705. [PMID: 32862492 DOI: 10.1002/cam4.3373] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
25 Wang C, Li M, Wang S, Jiang Z, Liu Y. LINC00665 Promotes the Progression of Multiple Myeloma by Adsorbing miR-214-3p and Positively Regulating the Expression of PSMD10 and ASF1B. Onco Targets Ther 2020;13:6511-22. [PMID: 32764956 DOI: 10.2147/OTT.S241627] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
26 Hanke M, Dubois J, Kausch I, Petkovic S, Sczakiel G. Oncoprotein 18 is necessary for malignant cell proliferation in bladder cancer cells and serves as a G3-specific non-invasive diagnostic marker candidate in urinary RNA. PLoS One 2020;15:e0229193. [PMID: 32614890 DOI: 10.1371/journal.pone.0229193] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Xia W, Gong D, Qin X, Cai Z. [MicroRNA-671-3p suppresses proliferation and invasion of breast cancer cells by targeting DEPTOR]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:42-8. [PMID: 32376551 DOI: 10.12122/j.issn.1673-4254.2020.01.07] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
28 Huang CS, Ho JY, Chiang JH, Yu CP, Yu DS. Exosome-Derived LINC00960 and LINC02470 Promote the Epithelial-Mesenchymal Transition and Aggressiveness of Bladder Cancer Cells. Cells 2020;9:E1419. [PMID: 32517366 DOI: 10.3390/cells9061419] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
29 He JW, Li DJ, Zhou JH, Zhu YL, Yu BQ. SP1-mediated upregulation of lncRNA LMCD1-AS1 functions a ceRNA for miR-106b-5p to facilitate osteosarcoma progression. Biochem Biophys Res Commun 2020;526:670-7. [PMID: 32248969 DOI: 10.1016/j.bbrc.2020.03.151] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
30 Xiang W, Lv Q, Shi H, Xie B, Gao L. Aptamer-based biosensor for detecting carcinoembryonic antigen. Talanta 2020;214:120716. [PMID: 32278406 DOI: 10.1016/j.talanta.2020.120716] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 25.0] [Reference Citation Analysis]
31 Yu X, Wang R, Han C, Wang Z, Jin X. A Panel of Urinary Long Non-coding RNAs Differentiate Bladder Cancer from Urocystitis. J Cancer 2020;11:781-7. [PMID: 31949480 DOI: 10.7150/jca.37006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
32 Gu R, Wang L, Tang M, Li SR, Liu R, Hu X. LncRNA Rpph1 protects amyloid-β induced neuronal injury in SK-N-SH cells via miR-122/Wnt1 axis. Int J Neurosci 2020;130:443-53. [PMID: 31718352 DOI: 10.1080/00207454.2019.1692834] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
33 Guo J, Chen Z, Jiang H, Yu Z, Peng J, Xie J, Li Z, Wu W, Cheng Z, Xiao K. The lncRNA DLX6-AS1 promoted cell proliferation, invasion, migration and epithelial-to-mesenchymal transition in bladder cancer via modulating Wnt/β-catenin signaling pathway. Cancer Cell Int 2019;19:312. [PMID: 31787849 DOI: 10.1186/s12935-019-1010-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
34 Shi Y, Zha J, Zuo M, Yan Q, Song H. Long noncoding RNA CHL1-AS1 promotes cell proliferation and migration by sponging miR-6076 to regulate CHL1 expression in endometrial cancer. J Cell Biochem 2020;121:2655-63. [PMID: 31736153 DOI: 10.1002/jcb.29486] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
35 Zou H, Li H. Knockdown of long non-coding RNA LINC00152 increases cisplatin sensitivity in ovarian cancer cells. Exp Ther Med 2019;18:4510-6. [PMID: 31777553 DOI: 10.3892/etm.2019.8066] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
36 Wu J, Chen Z, Zhang L, Cao J, Li X, Gong Z, Bo H, Zhang S, He D. Knockdown of LINC01116 inhibits cell migration and invasion in head and neck squamous cell carcinoma through epithelial-mesenchymal transition pathway. J Cell Biochem 2020;121:867-75. [PMID: 31452270 DOI: 10.1002/jcb.29331] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
37 Zhu H, Jin YM, Lyu XM, Fan LM, Wu F. Long noncoding RNA H19 regulates HIF-1α/AXL signaling through inhibiting miR-20b-5p in endometrial cancer. Cell Cycle 2019;18:2454-64. [PMID: 31411527 DOI: 10.1080/15384101.2019.1648958] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 8.7] [Reference Citation Analysis]
38 Pardini B, Sabo AA, Birolo G, Calin GA. Noncoding RNAs in Extracellular Fluids as Cancer Biomarkers: The New Frontier of Liquid Biopsies. Cancers (Basel) 2019;11:E1170. [PMID: 31416190 DOI: 10.3390/cancers11081170] [Cited by in Crossref: 87] [Cited by in F6Publishing: 94] [Article Influence: 29.0] [Reference Citation Analysis]
39 Wang C, Qi S, Xie C, Li C, Wang P, Liu D. Upregulation of long non-coding RNA XIST has anticancer effects on epithelial ovarian cancer cells through inverse downregulation of hsa-miR-214-3p. J Gynecol Oncol 2018;29:e99. [PMID: 30207107 DOI: 10.3802/jgo.2018.29.e99] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 11.0] [Reference Citation Analysis]
40 Setti Boubaker N, Cicchillitti L, Said R, Gurtner A, Ayed H, Blel A, Karray O, Essid MA, Gharbi M, Bouzouita A, Rammeh Rommeni S, Chebil M, Piaggio G, Ouerhani S. The clinical and prognostic value of miR-9 gene expression in Tunisian patients with bladder cancer. Mol Biol Rep 2019;46:4743-50. [DOI: 10.1007/s11033-019-04920-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
41 Celesti F, Celesti A, Galletta A, Fazio M, Villari M. optimizing the Research of DNA Sequences in a NoSQL Document Database: A Preliminary Study. 2019 IEEE Symposium on Computers and Communications (ISCC) 2019. [DOI: 10.1109/iscc47284.2019.8969697] [Reference Citation Analysis]
42 Li J, Xu Q, Wang W, Sun S. MIR100HG: a credible prognostic biomarker and an oncogenic lncRNA in gastric cancer. Biosci Rep 2019;39:BSR20190171. [PMID: 30886062 DOI: 10.1042/BSR20190171] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
43 Li Y, Shi B, Dong F, Zhu X, Liu B, Liu Y. Long Non-coding RNA DLEU1 Promotes Cell Proliferation, Invasion, and Confers Cisplatin Resistance in Bladder Cancer by Regulating the miR-99b/HS3ST3B1 Axis. Front Genet 2019;10:280. [PMID: 30984249 DOI: 10.3389/fgene.2019.00280] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 6.7] [Reference Citation Analysis]
44 Oeyen E, Hoekx L, De Wachter S, Baldewijns M, Ameye F, Mertens I. Bladder Cancer Diagnosis and Follow-Up: The Current Status and Possible Role of Extracellular Vesicles. Int J Mol Sci 2019;20:E821. [PMID: 30769831 DOI: 10.3390/ijms20040821] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 17.7] [Reference Citation Analysis]
45 Cacabelos R. Pathoepigenetics: The Role of Epigenetic Biomarkers in Disease Pathogenesis. Pharmacoepigenetics. Elsevier; 2019. pp. 139-89. [DOI: 10.1016/b978-0-12-813939-4.00005-x] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
46 Deng M, Yuan H, Liu S, Hu Z, Xiao H. Exosome-transmitted LINC00461 promotes multiple myeloma cell proliferation and suppresses apoptosis by modulating microRNA/BCL-2 expression. Cytotherapy 2019;21:96-106. [DOI: 10.1016/j.jcyt.2018.10.006] [Cited by in Crossref: 54] [Cited by in F6Publishing: 63] [Article Influence: 18.0] [Reference Citation Analysis]
47 Yazarlou F, Modarressi MH, Mowla SJ, Oskooei VK, Motevaseli E, Tooli LF, Nekoohesh L, Eghbali M, Ghafouri-Fard S, Afsharpad M. Urinary exosomal expression of long non-coding RNAs as diagnostic marker in bladder cancer. Cancer Manag Res 2018;10:6357-65. [PMID: 30568497 DOI: 10.2147/CMAR.S186108] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 13.0] [Reference Citation Analysis]
48 Liu G, Chen Z, Danilova IG, Bolkov MA, Tuzankina IA, Liu G. Identification of miR-200c and miR141-Mediated lncRNA-mRNA Crosstalks in Muscle-Invasive Bladder Cancer Subtypes. Front Genet 2018;9:422. [PMID: 30323832 DOI: 10.3389/fgene.2018.00422] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
49 Qin Z, Wang Y, Tang J, Zhang L, Li R, Xue J, Han P, Wang W, Qin C, Xing Q, Yang J, Zhang W. High LINC01605 expression predicts poor prognosis and promotes tumor progression via up-regulation of MMP9 in bladder cancer. Biosci Rep 2018;38:BSR20180562. [PMID: 30054424 DOI: 10.1042/BSR20180562] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]